SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies, today announced
that James S.J. Manuso, Ph.D., chairman and chief executive officer, ... read more
SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies, announced it
anticipates that it will begin operating under the name ... read more